Oxford Nanopore Technologies PLC (ONTTF)
1.355
-0.02
(-1.81%)
USD |
OTCM |
May 31, 16:00
Oxford Nanopore Technologies Price to Book Value: 1.425 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 1.425 |
| May 30, 2024 | 1.451 |
| May 29, 2024 | 1.451 |
| May 28, 2024 | 1.472 |
| May 24, 2024 | 1.472 |
| May 23, 2024 | 1.493 |
| May 22, 2024 | 1.472 |
| May 21, 2024 | 1.420 |
| May 20, 2024 | 1.462 |
| May 17, 2024 | 1.436 |
| May 16, 2024 | 1.525 |
| May 15, 2024 | 1.544 |
| May 14, 2024 | 1.504 |
| May 13, 2024 | 1.483 |
| May 10, 2024 | 1.521 |
| May 09, 2024 | 1.483 |
| May 08, 2024 | 1.483 |
| May 07, 2024 | 1.430 |
| May 06, 2024 | 1.525 |
| May 03, 2024 | 1.472 |
| May 02, 2024 | 1.420 |
| May 01, 2024 | 1.367 |
| April 30, 2024 | 1.283 |
| April 29, 2024 | 1.415 |
| April 26, 2024 | 1.311 |
| Date | Value |
|---|---|
| April 25, 2024 | 1.258 |
| April 24, 2024 | 1.321 |
| April 23, 2024 | 1.269 |
| April 22, 2024 | 1.269 |
| April 19, 2024 | 1.237 |
| April 18, 2024 | 1.258 |
| April 17, 2024 | 1.300 |
| April 16, 2024 | 1.311 |
| April 15, 2024 | 1.384 |
| April 12, 2024 | 1.436 |
| April 11, 2024 | 1.457 |
| April 10, 2024 | 1.478 |
| April 09, 2024 | 1.539 |
| April 08, 2024 | 1.494 |
| April 05, 2024 | 1.520 |
| April 04, 2024 | 1.573 |
| April 03, 2024 | 1.533 |
| April 02, 2024 | 1.557 |
| April 01, 2024 | 1.625 |
| March 28, 2024 | 1.614 |
| March 27, 2024 | 1.687 |
| March 26, 2024 | 1.656 |
| March 25, 2024 | 1.656 |
| March 22, 2024 | 1.771 |
| March 21, 2024 | 1.782 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.237
Minimum
Apr 19 2024
16.86
Maximum
Dec 30 2021
4.008
Average
2.977
Median
Price to Book Value Benchmarks
| Adaptimmune Therapeutics PLC | 11.74 |
| Biodexa Pharmaceuticals Plc | 1.588 |
| Verona Pharma PLC | 4.350 |
| NuCana PLC | 0.6398 |
| Autolus Therapeutics PLC | 1.915 |
Price to Book Value Related Metrics
| PS Ratio | 5.341 |
| Price | 1.355 |
| Earnings Yield | -17.47% |
| Market Cap | 1.169B |